BUDGET PUSH TO MAKE INDIA A GLOBAL BIOPHARMA HUB

• Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation) is a ₹10,000 crore, 5-year scheme announced in Union Budget 2026–27 to make India a global hub for biologics & biosimilars manufacturing.
• Bundled with NIPER expansion, 1,000+ accredited clinical trial sites, and CDSCO strengthening — a full-stack push covering R&D, talent, regulation, and manufacturing.
• Pharma is among 7 strategic & frontier sectors flagged for manufacturing scale-up in Budget 2026–27.